Your browser doesn't support javascript.
loading
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials.
He, Yundong; Xu, Weidong; Xiao, Yu-Tian; Huang, Haojie; Gu, Di; Ren, Shancheng.
Affiliation
  • He Y; Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai, China. ydhe@bio.ecnu.edu.cn.
  • Xu W; Department of Urology, Shanghai Changzheng Hospital, Shanghai, China.
  • Xiao YT; Department of Urology, Shanghai Changzheng Hospital, Shanghai, China.
  • Huang H; Department of Urology, Shanghai Changhai Hospital, Shanghai, China.
  • Gu D; Department of Urology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
  • Ren S; Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. sveong@163.com.
Signal Transduct Target Ther ; 7(1): 198, 2022 06 24.
Article in En | MEDLINE | ID: mdl-35750683
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Signal Transduction Limits: Humans / Male Language: En Journal: Signal Transduct Target Ther Year: 2022 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Signal Transduction Limits: Humans / Male Language: En Journal: Signal Transduct Target Ther Year: 2022 Type: Article Affiliation country: China